Increased excitability in tat-transgenic mice: Role of tat in HIV-related neurological disorders

Increased excitability in tat-transgenic mice: Role of tat in HIV-related neurological disorders

HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood but, based on in vitro studies, the HIV-1 Tat protein may play an important role. In this study, the effect of prolonged exposure to endogenous...

Full description

Bibliographic Details
Main Authors:	Silvia Zucchini, Anna Pittaluga, Egidio Brocca-Cofano, Maria Summa, Marina Fabris, Rita De Michele, Angela Bonaccorsi, Graziella Busatto, Giuseppe Barbanti-Brodano, Giuseppe Altavilla, Gianluca Verlengia, Pierangelo Cifelli, Alfredo Corallini, Antonella Caputo, Michele Simonato
Format:	Article
Language:	English
Published:	Elsevier 2013-07-01
Series:	Neurobiology of Disease
Subjects:	HIV-1-tat-transgenic mice HIV-1 associated neurocognitive disorders Seizures Kainate Neurodegeneration
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996113000661

Similar Items

Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses
by: Deepanwita Bose, et al.
Published: (2015-09-01)

The role of HIV Tat protein in HIV-related cardiovascular diseases
by: Yanan Jiang, et al.
Published: (2018-05-01)

HIV-1 Tat: Role in Bystander Toxicity
by: David Ajasin, et al.
Published: (2020-02-01)

HIV, Tat and dopamine transmission
by: Peter J. Gaskill, et al.
Published: (2017-09-01)

HIV-1 Tat C-mediated regulation of tumor necrosis factor receptor-associated factor-3 by microRNA 32 in human microglia
by: Mishra Ritu, et al.
Published: (2012-06-01)

HIV-1 Tat alters neuronal intrinsic excitability
by: Walter Francesconi, et al.
Published: (2018-05-01)

Mécanistique de l'incorporation de la protéine Tat du VIH-1 dans les particules virales
by: Schatz, Malvina
Published: (2018)

Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease
by: Aurelio Cafaro, et al.
Published: (2019-08-01)

HIV-1 Tat Length: Comparative and Functional Considerations
by: Anthony R. Mele, et al.
Published: (2020-03-01)

Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART.
by: Antonella Tripiciano, et al.
Published: (2021-04-01)

An HIV-Tat inducible mouse model system of childhood HIV-associated nephropathy
by: Pingtao Tang, et al.
Published: (2020-10-01)

HIV-1 Tat: Its Dependence on Host Factors is Crystal Clear
by: Alan D. Frankel, et al.
Published: (2010-10-01)

Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure
by: Hongping Jin, et al.
Published: (2020-04-01)

Molecular Mechanism Involved in HIV-Tat Mediated inhibition of LPS-Induced IL-23 and IL-27 Production in Human Macrophages
by: Gajanayaka, Niranjala
Published: (2015)

HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia
by: Giovanni Sarnelli, et al.
Published: (2018-03-01)

HIV latency reversing agents act through Tat post translational modifications
by: Georges Khoury, et al.
Published: (2018-05-01)

The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders
by: Susana T Valente, et al.
Published: (2015-10-01)

Regions of the CD127 Cytoplasmic Tail Necessary for HIV-1 Tat Binding
by: Cherid, Hafsa
Published: (2014)

Novel role of mortalin in attenuating HIV-1 Tat-mediated astrogliosis
by: Priyanka, et al.
Published: (2020-09-01)

Extracellular HIV-1 Tat Mediates Increased Glutamate in the CNS Leading to Onset of Senescence and Progression of HAND
by: Jamie Marino, et al.
Published: (2020-06-01)

Solubility and Conformational Studies of the Intrinsically Disordered HIV-1 Tat1-72 Protein
by: Babiak, Taras
Published: (2011)

Solubility and Conformational Studies of the Intrinsically Disordered HIV-1 Tat1-72 Protein
by: Babiak, Taras
Published: (2011)

Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments
by: Monray E. Williams, et al.
Published: (2020-03-01)

Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis
by: Huaqian Dong, et al.
Published: (2019-02-01)

Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors
by: Susana Valente, et al.
Published: (2012-11-01)

Développement d’une nouvelle classe d'agents de sortie de latence du VIH-1 ciblant la protéine virale Tat
by: Tong, Phuoc Bao Viet
Published: (2019)

Prevention of HIV-1 TAT Protein-Induced Peripheral Neuropathy and Mitochondrial Disruption by the Antimuscarinic Pirenzepine
by: May Madi Han, et al.
Published: (2021-06-01)

Resistance to the Tat Inhibitor Didehydro-Cortistatin A Is Mediated by Heightened Basal HIV-1 Transcription
by: Guillaume Mousseau, et al.
Published: (2019-07-01)

Unexpected Mutations in HIV-1 That Confer Resistance to the Tat Inhibitor Didehydro-Cortistatin A
by: Andrew P. Rice
Published: (2019-07-01)

HIV-1 Tat Binding to PCAF Bromodomain: Structural Determinants from Computational Methods
by: Paolo Carloni, et al.
Published: (2012-08-01)

Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-α-mediated neurotoxicity
by: Lara Buscemi, et al.
Published: (2007-06-01)

Induced Degradation of Tat by Nucleocapsid (NC) via the Proteasome Pathway and Its Effect on HIV Transcription
by: Heejoon Myung, et al.
Published: (2013-04-01)

HIV Tat-Mediated Induction of Monocyte Transmigration Across the Blood–Brain Barrier: Role of Chemokine Receptor CXCR3
by: Fang Niu, et al.
Published: (2021-08-01)

Nuclear magnetic resonance and dynamic characterization of the intrinsically disordered HIV-1 Tat protein
by: Shojania, Shaheen
Published: (2007)

Cloning, Expression and Purification of the Recombinant HIV-1 Tat-Nef Fusion Protein in Prokaryotic Expression System
by: Somayeh Kadkhodayan, et al.
Published: (2016-07-01)

Prediction of immune pressure on HIV-1 regulatory gene tat by human host through bioinformatics tools
by: Zafrul Hasan, et al.
Published: (2020-12-01)

Reflexões sobre o uso clínico do TAT na contemporaneidade Reflection about the clinical use of TAT in contemporaneity
by: Ana Paula Parada, et al.
Published: (2011-04-01)

DDX5 potentiates HIV-1 transcription as a co-factor of Tat
by: Nyaradzai Sithole, et al.
Published: (2020-03-01)

Mutational Analysis of the HIV-1 Tat Protein and its Role in Downregulating CD127 on CD8 T Cells
by: Sugden, Scott M.
Published: (2013)

Mutational Analysis of the HIV-1 Tat Protein and its Role in Downregulating CD127 on CD8 T Cells
by: Sugden, Scott M.
Published: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m1219q9qeddmetvjmlg12l8v5r